IQVIA (IQV) stock
NYSE
As of the Nov 5, 2026 close (U.S. Eastern)
Events and reference metrics · 1
- Market cap
- $43.7B
- As of Nov 5, 2026
- P/E
- 31.35x
- Trailing twelve months
- P/B
- 6.56x
- Latest reported equity
- P/S
- 2.52x
- Trailing twelve months
- ROE
- 20.9%
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 5, 2026 and may differ from the current price.
- Market cap
- $43.7B
- As of Nov 5, 2026
- P/E
- 31.35x
- Trailing twelve months
- P/B
- 6.56x
- Latest reported equity
- P/S
- 2.52x
- Trailing twelve months
- ROE
- 20.9%
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 5, 2026 and may differ from the current price.
Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.
Price date for the multiples · Nov 5, 2026 · Financial period · Trailing twelve months
P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock
P/E
31.35x
P/B
6.56x
P/S
2.52x
Earnings and dividend metrics▾
Earnings
EPS
$8.45
Earnings per share
BPS
$40.36
Book value per share
ROE
20.9%
Return on equity
- EPS — what one share earned over the last four quarters. This company earned $8.45 per share.
- BPS — net assets divided by the number of shares. Each share is backed by $40.36 of net assets.
- ROE — how much the company earned on shareholder equity over a year: 20.9%.
ⓘ What are these valuation metrics?▾
P/E = share price ÷ earnings per share (EPS)
P/B = share price ÷ book value per share (BPS)
P/S = share price ÷ sales per share
P/E shows how many times annual earnings per share the price is; not all earnings are paid to shareholders. P/B compares the price with net assets, and P/S with sales.
Higher or lower is not good or bad by itself. Typical levels differ by industry; read P/B alongside ROE and P/S alongside margins.
ChickenStock computes these from SEC financial filings: net income and revenue are summed over the latest four quarters, and equity is the latest reported balance.
A negative P/E means a net loss. Reference information only, not a recommendation to buy or sell.
Latest earnings
SEC filingsJul–Sep 2026(FY2026 Q3)
Revenue increased 8.0% from the same period a year earlier.
Key reported figures come first. Select one to see the same quarter across three years.
Revenue · same quarter, three years
Year-ago quarter $4.1B+8.0%
$3.9B
Jul–Sep '24
$4.1B
Jul–Sep '25
$4.43B
Jul–Sep '26
The next earnings date has not been confirmed yet.
ⓘ Notes on these figures▾
- Results for Jul–Sep 2026 are from the 10-Q submitted to SEC EDGAR on Oct 27, 2026.
- Earnings per share increased 8.8% from the same quarter a year earlier.
- Revenue increased 8.0% from the same quarter a year earlier.
- Operating income increased 3.4% from the same quarter a year earlier.
- Net income increased 5.7% from the same quarter a year earlier.
Filed Oct 27, 2026 · 10-Q · SEC EDGAR · View original
Reported results are from SEC EDGAR filings. Reference information only, not investment advice.
Insider transactions
Recent Form 4 filings grouped by person, date and transaction type.
- Berkshire James G.See Remarks · Sep 2, 2026Open-market sale2,668 shares · $697KAvg. price $261.3310,890 shares held after
- Berkshire James G.See Remarks · Sep 2, 2026Disposition to the issuer2,713 shares · $710KAvg. price $261.548,177 shares held after
- Berkshire James G.See Remarks · Sep 2, 2026Option exercise5,381 shares · $709KAvg. price $131.8213,558 shares held after
- STAUB W RICHARDSee Remarks · Aug 3, 2026Open-market sale5,500 shares · $1.3MAvg. price $232.6813,312 shares held after
- Patel BhavikSee Remarks · Jul 31, 2026Open-market sale1,855 shares · $436KAvg. price $235.271,348 shares held after
- BOUSBIB ARISee Remarks · Jul 29, 2026Open-market sale106,279 shares · $26.1MAvg. price $245.5054
Show 4 price lots
- 53,191 shares × $244.78$13.0M
- 44,039 shares × $246.08$10.8M
- 4,584 shares × $246.85$1.1M
- 4,465 shares × $247.1$1.1M
- Sherbet EricSee Remarks · Jul 29, 2026Open-market sale5,000 shares · $1.2MAvg. price $249.1620,999 shares held after
- Cherofsky KeriannSee Remarks · Jul 29, 2026Open-market sale558 shares · $137KAvg. price $245.212,989 shares held after
- BOUSBIB ARISee Remarks · Jul 29, 2026Option exercise156,206 shares · $12.2MAvg. price $78.21992,147 shares held after
- BOUSBIB ARISee Remarks · Jul 29, 2026Disposition to the issuer49,927 shares · $12.2MAvg. price $244.6995
Show 2 price lots
- 47,858 shares × $244.6$11.7M
- 2,069 shares × $247$511K
Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.
Recent SEC filings
40 filingsRecent filing summaries
Newest first by publication date · may differ from the filing date
- AI summary10-QThe company said its Q3 2026 revenue rose $328 million (8.0%) from a year earlier, and its revenue for the first 9 months rose $1,001 million (8.4%). Constant currency growth for Q3 was approximately $353 million (8.6%).Published Oct 27, 2026 · Filed Oct 27, 2026Read the summary →
- AI summary8-KIQVIA said revenue for Q2 2026 was $4,368 million, up 8.7% year-over-year on a reported basis and 8.5% at constant currency. Commercial Solutions revenue was $1,793 million and Research & Development Solutions revenue was $2,575 million.Published Oct 2, 2026 · Filed Jul 28, 2026Read the summary →
- AI summary8-KIQVIA Holdings Inc. said its wholly owned subsidiary IQVIA Inc. completed the issuance and sale of €950,000,000 in gross proceeds of 4.625% senior notes due 2033 on June 11, 2026.Published Oct 1, 2026 · Filed Jun 11, 2026Read the summary →
- The company said its Q3 2026 revenue rose $328 million (8.0%) from a year earlier, and its revenue for the first 9 months rose $1,001 million (8.4%). Constant currency growth for Q3 was approximately $353 million (8.6%).Read the full analysis →
- IQVIA said revenue for Q2 2026 was $4,368 million, up 8.7% year-over-year on a reported basis and 8.5% at constant currency. Commercial Solutions revenue was $1,793 million and Research & Development Solutions revenue was $2,575 million.Read the full analysis →
Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.
Company overview
Expand ▾
IQVIA (IQV) stock information
NYSE
IQVIA (IQV) is listed on NYSE. Its market capitalization is about $43.7B. On trailing-twelve-month earnings the P/E ratio is 31.35, and the P/B ratio is 6.56. Return on equity is 20.9%. These figures are computed in-house from official filings and are reference information only.
IQVIA — frequently asked questions
- What is the P/E ratio of IQVIA (IQV)?
- On a trailing-twelve-month basis, IQV trades at a P/E ratio of 31.35. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
- What is the market capitalization of IQVIA?
- IQV has a market capitalization of about $43.7B. The figure moves with the share price and is refreshed each trading day.
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.